Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma

Stephan Regenbogen(University Children's Hospital Tübingen), Guido Seitz(Philipps University of Marburg)
International Journal of Oncology
May 5, 2020
Cited by 9


Related Papers